Alibaba invents a blockchain platform for handling payments in court ordered judgments.
In this week’s featured patent applications, we cover the latest from Alibaba, Apple, IBM, Boston Scientific, Abbott, Medtronic, Merck, Roche, and Novartis.
Alibaba Pursues a Patent for Blockchain-Based Judgment Execution
U.S. patent application, US20200334771, relates to blockchain-based trusted platforms for enabling judgment execution. The platform receives requests associated with an account of a blockchain application for collecting a monetary award issued in a court order. Payment accounts of a creditor and debtor are identified and an amount from the debtor to the creditor is transferred and recorded automatically. The illustration below depicts a block diagram of a system for providing dispute resolution.
Apple Eyes a Patent for a Stylus-Based Input System for a Head-Mounted Device
U.S. patent application, US20200333891, discloses a tracking system including a stylus with a light emitter and a head-mounted device with an optical sensor. The optical sensor detects the light emitted from the stylus for determining the position of the stylus based on the emitted light. The tracking system is illustrated below.
IBM Files a Patent Application Related to Dynamic Prioritization of Action Items
U.S. patent application, US20200334614, discloses a method for retrieving an electronically rendered text from sampled text sources upon recognizing a user-related task conveyed within the text, and generating multiple action items corresponding to the user-related task. The action items are prioritized based on priority factors associated with the user-related task.
Roche Seeks a Patent for the Diagnosis of Stroke
U.S. patent application, US20200333360, discusses a method for diagnosing transient ischemic attacks by calculating the ratio of NT-proBNP (N-terminal pro-brain natriuretic peptide) and NT-proANP (N-terminal pro-atrial natriuretic peptide) and comparing the ratio to a reference amount.
Novartis Pursues a Patent for Treatment of Depressive Disorders
U.S. patent application, US20200335191, discloses a system for treating depressive disorders associated with multiple sclerosis by combining a disease-modifying therapy and a computerized behavioral therapy. The following figure shows the computerized system for treating depressive symptoms.
Abbott Pursues a Patent for a Communication System in an Analyte Monitoring Environment
U.S. patent application, US20200336407, describes a method for wireless communication between two devices for in vivo detection of an analyte level such as glucose in a bodily fluid and maintaining compliance with timing requirements of communication protocols. The figure below illustrates the analyte monitoring environment.
Medtronic Seeks a Patent for a Stented Prosthetic Heart Valve
U.S. patent application, US20200330223, describes a stented prosthetic heart valve that consists of heart valve leaflets supported on a stent frame along with an inner skirt for supporting the leaflets and an outer wrap for leakage prevention. The figure below is a perspective view of the stented prosthetic heart valve as described above.
Boston Scientific Files a Patent Application for Dynamic Visualization of Neuronal Subpopulation Interactions
U.S. patent application, US20200330778, relates to a graphical user interface that allows a user to select stimulation waveforms and display a representation of constructive and destructive activation interactions of the stimulation waveforms. The figure below shows the interface provided on a clinician’s programmer system.
Merck Aims to Patent Solar Cell Modules
U.S. patent application, US20200335643, describes solar cell modules having a layer of effect pigments consisting of a transparent or semi-transparent flake-form substrate coated with one or more layers of transparent or semi-transparent materials.